Foundation Models in Drug Discovery: Recursion VP of AI Stephen MacKinnon | Ray Summit 2024
Stephen MacKinnon is the VP of Applied ML at Recursion Pharmaceuticals, a next-generation biopharmaceutical company that is rewriting the rules of drug discovery.
Biology benefits from scaling laws, and Recursion is operating at a larger scale than anyone else, taking advantage of thousands of GPUs and petabytes of image and video data to screen millions of molecules and run hundreds of millions of experiments.
In addition, Recursion has automated the data collection process with robotic systems to industrialize data collection in a high throughput and highly reproducible manner.
Foundation models are transforming drug discovery across genomics, transcriptomics, proteomics, phenomics, ADME, and real-world patient data.
This presentation offers a compelling look at the future of AI-driven pharmaceutical innovation. This keynote is a window into the cutting edge of AI in pharmaceuticals.
--
Interested in more?
Watch the full Day 1 Keynote: • Ray Summit 2024 Keynote Day 1 | Where...
Watch the full Day 2 Keynote • Ray Summit 2024 Keynote Day 2 | Where...
Check out the Ray Summit breakout session recordings!
--
🔗 Connect with us:
Subscribe to our YouTube channel: / @anyscale
Twitter: https://x.com/anyscalecompute
LinkedIn: / joinanyscale
Website: https://www.anyscale.com
